Segment Information

9 Months Ended

Sep. 30, 2018

The Company currently operates in one business segment, pharmaceuticals, and is focused on the development and commercialization of two commercial products. The Company's Interim Chief Executive Officer and Chief Operating Officer is the Company's chief operating decision maker (“CODM”). The Company does not operate any separate lines of business or separate business entities with respect to its products. Accordingly, the Company does not accumulate discrete financial information with respect to separate service lines and does not have separately reportable segments. Enterprise-wide disclosures about net revenues and long-lived assets by geographic area and information relating to major customers are presented below.

Net Revenues

The following table summarizes total net revenues from external customers by product and by geographic region, based on the location of the customer, for the three months ended September 30, 2018 and 2017.



	Three Months Ended September 30,
	2018										2017
	U.S.		Japan		Brazil		Other Foreign Countries		Total		U.S.		Japan		Brazil		Other Foreign Countries		Total
	(in thousands)										(in thousands)
Lomitapide	$	8,128	$	2,757	$	—	$	3,365	$	14,250	$	10,304	$	1,718	$	—	$	3,170	$	15,192
Metreleptin	12,293		91		706		2,994		16,084		11,311		24		96		2,046		13,477
Total	$	20,421	$	2,848	$	706	$	6,359	$	30,334	$	21,615	$	1,742	$	96	$	5,216	$	28,669

The following table summarizes total net revenues from external customers by product and by geographic region, based on the location of the customer, for the nine months ended September 30, 2018 and 2017.



	Nine Months Ended September 30,
	2018										2017
	U.S.		Japan		Brazil		Other Foreign Countries		Total		U.S.		Japan		Brazil		Other Foreign Countries		Total
	(in thousands)										(in thousands)
Lomitapide	$	27,228	$	7,560	$	—	$	9,098	$	43,886	$	32,236	$	3,531	$	5,939	$	10,224	$	51,930
Metreleptin	34,542		139		1,876		9,279		45,836		37,652		71		5,082		4,795		47,600
Total	$	61,770	$	7,699	$	1,876	$	18,377	$	89,722	$	69,888	$	3,602	$	11,021	$	15,019	$	99,530

During the three months ended September 30, 2018 and 2017, net revenues generated from customers outside of the U.S., Japan and Brazil, as listed in the column “Other Foreign Countries,” were primarily derived from Colombia. Net revenues generated from customers located in other foreign countries were primarily derived from Canada, Colombia, France, and Italy during the nine months ended September 30, 2018 and from Colombia and Greece during the nine months ended September 30, 2017.

Significant Customers

For the three months ended September 30, 2018, one customer accounted for 67% of the Company’s net revenues and accounted for 50% of the Company's September 30, 2018 accounts receivable balance. For the three months ended September 30, 2017, two customers accounted for 75% of the Company's net revenues and 64% of the Company's September 30, 2017 accounts receivable balance.

For the nine months ended September 30, 2018, one customer accounted for 69% of the Company's net revenues, and for the nine months ended September 30, 2017, two customers accounted for 70% of the Company's net revenues.

Long-lived Assets

The Company’s long-lived assets are primarily comprised of intangible assets and property and equipment. As of September 30, 2018 and December 31, 2017, 100% of the Company's intangible assets were held by the Company's indirect wholly owned subsidiary, Aegerion. Of that, 65% of the intangible assets were attributable to Aegerion's U.S. business, with the remaining 35% attributable to Aegerion's European holding company, as of both September 30, 2018 and December 31, 2017.

As of both September 30, 2018 and December 31, 2017, 71% of the Company's property and equipment resided in the Company's U.S. subsidiaries, with the remaining assets residing in the Company's Canadian and other foreign subsidiaries.